Ferran Nadeu
Research group
- Immunogenomics and evolution of lymphoid neoplasms Junior group leader (R3B)
About me
Ferran Nadeu holds a degree in Biotechnology (University of Barcelona, UB, 2013), a Master's degree in Bioinformatics (Pompeu Fabra University, 2015), and a PhD in Biomedicine (UB, 2020). He has published more than 90 scientific articles in the fields of the molecular biology of lymphoid neoplasms and cancer genomics. Since 2026, he is a Junior Group Leader at FRCB-IDIBAPS. Funded by national and international agencies, including the European Research Council, his research focuses on the immunogenomic mechanisms that determine the origin and evolution of lymphoid neoplasms, before and after treatment
Featured publications
-
The biology and evolution of Richter transformation in chronic lymphocytic leukemia
Authors:Reference: SEMINARS IN CANCER BIOLOGY 2026. -
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Authors:Reference: LEUKEMIA 2025. -
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation
Authors:Reference: LEUKEMIA 2024. -
All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
Authors:Reference: HemaSphere 2023. -
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Authors:Reference: NATURE GENETICS 2022. -
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Authors:Reference: NATURE MEDICINE 2022. -
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Authors:Reference: BLOOD 2021. -
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Authors:Reference: BLOOD 2020. -
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Authors:Reference: Nature Communications 2020. -
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Authors:Reference: BLOOD 2016.
Featured Projects
-
Deciphering the life histories of chronic lymphocytic leukemia to improve clinical outcome (CLL-STORY)
Principal investigator: Ferran Nadeu PratFunder: European Research Council (ERC)Code: 101222226Duration: 01/01/2026 - 31/12/2030 -
Deciphering the life stories of chronic lymphocytic leukemia to improve clinical outcome (Contrato Miguel Servet 2025)
Principal investigator: Ferran Nadeu PratFunder: Instituto de Salud Carlos IIICode: CP25/00084Duration: 01/01/2026 - 31/12/2030 -
Caracterización de la evolución clonal y las interacciones del microambiente que dictan la progresión de la leucemia linfocítica crónica y la transformación de Richter
Principal investigator: Ferran Nadeu PratFunder: Fundacion Espanola de Hematologia y Hemoterapia (FEHH)Code: FEHH_BECAS24_01Duration: 01/01/2025 - 31/12/2025 -
Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints
Principal investigator: Ferran Nadeu PratFunder: European Hematology Association (EHA)Code: RG-202012-00245Duration: 01/01/2022 - 31/12/2024 -
Tracking the progression and transformation of chronic lymphocytic leukemia
Principal investigator: Ferran Nadeu PratFunder: American Association for Cancer Research (AACR)Code: 21-40-11-NADEDuration: 01/07/2021 - 30/06/2023
